Doug Jamison is listed as a director on 3 SEC Form D filings by 2 issuers between Nov 2009 and Dec 2015: ORIG3N, Inc. (Boston, MA — industry reported as "Other" — 2015; $26.2M reported sold to 11 investors) and ANCORA PHARMACEUTICALS INC (Medford, MA — biotechnology — 2009; $800K reported sold to 1 investors).
What this means 2 separate companies raised money with this person listed as director, over about 6 years. Across those companies the filings report $27M sold in total.
Listed alongside Clay Thorp (2 shared filings), Jonathan Meltzer (2 shared filings), Kate Blanchard (2 shared filings), Robin Y. Smith (2 shared filings), Barry Buckland (1 shared filing) and 8 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Doug. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for Doug Jamison and found 5 differences: 20% of the money raised went to insiders; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.